rs61735664
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001378609.3(OTOGL):āc.5060A>Gā(p.Asn1687Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0483 in 1,600,182 control chromosomes in the GnomAD database, including 2,220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.036 ( 158 hom., cov: 32)
Exomes š: 0.050 ( 2062 hom. )
Consequence
OTOGL
NM_001378609.3 missense
NM_001378609.3 missense
Scores
1
8
6
Clinical Significance
Conservation
PhyloP100: 7.16
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0050604045).
BP6
Variant 12-80341957-A-G is Benign according to our data. Variant chr12-80341957-A-G is described in ClinVar as [Benign]. Clinvar id is 226950.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-80341957-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0526 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.5060A>G | p.Asn1687Ser | missense_variant | 44/59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.5060A>G | p.Asn1687Ser | missense_variant | 44/59 | 5 | NM_001378609.3 | ENSP00000447211.2 | ||
OTOGL | ENST00000646859.1 | c.4925A>G | p.Asn1642Ser | missense_variant | 48/63 | ENSP00000496036.1 | ||||
OTOGL | ENST00000298820.7 | c.359A>G | p.Asn120Ser | missense_variant | 5/18 | 5 | ENSP00000298820.3 |
Frequencies
GnomAD3 genomes AF: 0.0360 AC: 5482AN: 152164Hom.: 159 Cov.: 32
GnomAD3 genomes
AF:
AC:
5482
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0370 AC: 8624AN: 233194Hom.: 220 AF XY: 0.0373 AC XY: 4701AN XY: 125920
GnomAD3 exomes
AF:
AC:
8624
AN:
233194
Hom.:
AF XY:
AC XY:
4701
AN XY:
125920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0496 AC: 71810AN: 1447900Hom.: 2062 Cov.: 29 AF XY: 0.0489 AC XY: 35170AN XY: 719514
GnomAD4 exome
AF:
AC:
71810
AN:
1447900
Hom.:
Cov.:
29
AF XY:
AC XY:
35170
AN XY:
719514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0360 AC: 5479AN: 152282Hom.: 158 Cov.: 32 AF XY: 0.0348 AC XY: 2592AN XY: 74456
GnomAD4 genome
AF:
AC:
5479
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
2592
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
215
ALSPAC
AF:
AC:
217
ESP6500AA
AF:
AC:
41
ESP6500EA
AF:
AC:
451
ExAC
AF:
AC:
4366
Asia WGS
AF:
AC:
34
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Asn1678Ser in exon 43 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 5.5% (451/8174) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs61735664). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 25, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D
REVEL
Benign
Sift
Uncertain
.;.;D
Sift4G
Uncertain
.;.;D
Vest4
0.51
MPC
0.17
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at